,dataset_name,cell_type,cell_type_ontology_id,donor_id,sex,race,development_stage,count,percentage
0,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",T cell,CL:0000084,KR_SGI_H151,male,Korean,48-year-old human stage,37,2.3536895674300253
1,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",erythrocyte,CL:0000232,KR_SGI_H151,male,Korean,48-year-old human stage,1,0.06361323155216285
2,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",platelet,CL:0000233,KR_SGI_H151,male,Korean,48-year-old human stage,33,2.099236641221374
3,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",B cell,CL:0000236,KR_SGI_H151,male,Korean,48-year-old human stage,28,1.7811704834605597
4,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",monocyte,CL:0000576,KR_SGI_H151,male,Korean,48-year-old human stage,74,4.707379134860051
5,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",natural killer cell,CL:0000623,KR_SGI_H151,male,Korean,48-year-old human stage,14,0.8905852417302799
6,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD4-positive, alpha-beta T cell",CL:0000624,KR_SGI_H151,male,Korean,48-year-old human stage,13,0.826972010178117
7,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",mature B cell,CL:0000785,KR_SGI_H151,male,Korean,48-year-old human stage,5,0.3180661577608142
8,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",memory B cell,CL:0000787,KR_SGI_H151,male,Korean,48-year-old human stage,95,6.043256997455471
9,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",naive B cell,CL:0000788,KR_SGI_H151,male,Korean,48-year-old human stage,54,3.435114503816794
10,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD8-positive, alpha-beta cytotoxic T cell",CL:0000794,KR_SGI_H151,male,Korean,48-year-old human stage,45,2.8625954198473282
11,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",gamma-delta T cell,CL:0000798,KR_SGI_H151,male,Korean,48-year-old human stage,13,0.826972010178117
12,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",regulatory T cell,CL:0000815,KR_SGI_H151,male,Korean,48-year-old human stage,10,0.6361323155216284
13,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","naive thymus-derived CD4-positive, alpha-beta T cell",CL:0000895,KR_SGI_H151,male,Korean,48-year-old human stage,73,4.643765903307888
14,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","naive thymus-derived CD8-positive, alpha-beta T cell",CL:0000900,KR_SGI_H151,male,Korean,48-year-old human stage,11,0.6997455470737913
15,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","central memory CD4-positive, alpha-beta T cell",CL:0000904,KR_SGI_H151,male,Korean,48-year-old human stage,162,10.305343511450381
16,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","effector memory CD4-positive, alpha-beta T cell",CL:0000905,KR_SGI_H151,male,Korean,48-year-old human stage,33,2.099236641221374
17,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD8-positive, alpha-beta memory T cell",CL:0000909,KR_SGI_H151,male,Korean,48-year-old human stage,38,2.4173027989821882
18,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD4-positive, alpha-beta cytotoxic T cell",CL:0000934,KR_SGI_H151,male,Korean,48-year-old human stage,6,0.38167938931297707
19,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD16-negative, CD56-bright natural killer cell, human",CL:0000938,KR_SGI_H151,male,Korean,48-year-old human stage,3,0.19083969465648853
20,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD16-positive, CD56-dim natural killer cell, human",CL:0000939,KR_SGI_H151,male,Korean,48-year-old human stage,97,6.1704834605597965
21,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",mucosal invariant T cell,CL:0000940,KR_SGI_H151,male,Korean,48-year-old human stage,26,1.653944020356234
22,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",CD14-positive monocyte,CL:0001054,KR_SGI_H151,male,Korean,48-year-old human stage,632,40.20356234096692
23,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea","CD14-low, CD16-positive monocyte",CL:0002396,KR_SGI_H151,male,Korean,48-year-old human stage,36,2.2900763358778624
24,"AIDA Phase 1: Chinese, Indian, Japanese, Korean, and Malay donors in Japan, Singapore, and South Korea",CD1c-positive myeloid dendritic cell,CL:0002399,KR_SGI_H151,male,Korean,48-year-old human stage,33,2.099236641221374
